Back to Search Start Over

Aetiology and incidence of diarrhoea requiring hospitalisation in children under 5 years of age in 28 low-income and middle-income countries: findings from the Global Pediatric Diarrhea Surveillance network.

Authors :
Cohen AL
Platts-Mills JA
Nakamura T
Operario DJ
Antoni S
Mwenda JM
Weldegebriel G
Rey-Benito G
de Oliveira LH
Ortiz C
Daniels DS
Videbaek D
Singh S
Njambe E
Sharifuzzaman M
Grabovac V
Nyambat B
Logronio J
Armah G
Dennis FE
Seheri ML
Magagula N
Mphahlele J
Fumian TM
Maciel ITA
Gagliardi Leite JP
Esona MD
Bowen MD
Samoilovich E
Semeiko G
Abraham D
Giri S
Praharaj I
Kang G
Thomas S
Bines J
Liu N
Kyu HH
Doxey M
Rogawski McQuade ET
McMurry TL
Liu J
Houpt ER
Tate JE
Parashar UD
Serhan F
Source :
BMJ global health [BMJ Glob Health] 2022 Sep; Vol. 7 (9).
Publication Year :
2022

Abstract

Introduction: Diarrhoea remains a leading cause of child morbidity and mortality. Systematically collected and analysed data on the aetiology of hospitalised diarrhoea in low-income and middle-income countries are needed to prioritise interventions.<br />Methods: We established the Global Pediatric Diarrhea Surveillance network, in which children under 5 years hospitalised with diarrhoea were enrolled at 33 sentinel surveillance hospitals in 28 low-income and middle-income countries. Randomly selected stool specimens were tested by quantitative PCR for 16 causes of diarrhoea. We estimated pathogen-specific attributable burdens of diarrhoeal hospitalisations and deaths. We incorporated country-level incidence to estimate the number of pathogen-specific deaths on a global scale.<br />Results: During 2017-2018, 29 502 diarrhoea hospitalisations were enrolled, of which 5465 were randomly selected and tested. Rotavirus was the leading cause of diarrhoea requiring hospitalisation (attributable fraction (AF) 33.3%; 95% CI 27.7 to 40.3), followed by Shigella (9.7%; 95% CI 7.7 to 11.6), norovirus (6.5%; 95% CI 5.4 to 7.6) and adenovirus 40/41 (5.5%; 95% CI 4.4 to 6.7). Rotavirus was the leading cause of hospitalised diarrhoea in all regions except the Americas, where the leading aetiologies were Shigella (19.2%; 95% CI 11.4 to 28.1) and norovirus (22.2%; 95% CI 17.5 to 27.9) in Central and South America, respectively. The proportion of hospitalisations attributable to rotavirus was approximately 50% lower in sites that had introduced rotavirus vaccine (AF 20.8%; 95% CI 18.0 to 24.1) compared with sites that had not (42.1%; 95% CI 33.2 to 53.4). Globally, we estimated 208 009 annual rotavirus-attributable deaths (95% CI 169 561 to 259 216), 62 853 Shigella -attributable deaths (95% CI 48 656 to 78 805), 36 922 adenovirus 40/41-attributable deaths (95% CI 28 469 to 46 672) and 35 914 norovirus-attributable deaths (95% CI 27 258 to 46 516).<br />Conclusions: Despite the substantial impact of rotavirus vaccine introduction, rotavirus remained the leading cause of paediatric diarrhoea hospitalisations. Improving the efficacy and coverage of rotavirus vaccination and prioritising interventions against Shigella , norovirus and adenovirus could further reduce diarrhoea morbidity and mortality.<br />Competing Interests: Competing interests: None declared.<br /> (© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.)

Details

Language :
English
ISSN :
2059-7908
Volume :
7
Issue :
9
Database :
MEDLINE
Journal :
BMJ global health
Publication Type :
Academic Journal
Accession number :
36660904
Full Text :
https://doi.org/10.1136/bmjgh-2022-009548